Business Context and Reporting Period
Company: HAPC, Inc. (formerly Healthcare Acquisition Partners Corp.), a Delaware corporation operating as a blank check company (SPAC) in the development stage.
Reporting Period: Quarterly period ended March 31, 2007.
Business Objective: The Company was formed to acquire one or more operating businesses primarily in the healthcare sector. As of the filing date, the Company has entered into a definitive Stock Purchase Agreement to acquire InfuSystem, Inc. (a subsidiary of I-Flow Corporation) for a total consideration of $140,000,000. The transaction is subject to stockholder approval and a termination date extended to June 29, 2007.
Key Financial Metrics
| Metric | Three Months Ended Mar 31, 2007 | Three Months Ended Mar 31, 2006 |
|---|---|---|
| Revenues | $0 | $0 |
| Net Income (Loss) | $1,774,808 | $(2,198,721) |
| Operating Loss | $(1,018,078) | $(2,197,189) |
| Cash and Cash Equivalents | $61,863 | $9,197 |
| Investments Held in Trust | $99,297,879 | N/A (IPO consummated April 2006) |
| Total Assets | $101,469,015 | N/A |
| Total Current Liabilities | $14,312,866 | N/A |
| Warrant Liabilities | $7,087,606 | N/A |
| Stockholders' Equity | $67,306,503 | N/A |
Liquidity: The Company holds approximately $99.3 million in a trust account invested in U.S. Treasury money market funds. Cash outside the trust is minimal ($61,863), with the Company relying on the trust account and potential financing to fund the acquisition.
Material Changes vs. Prior Period
- Profitability Shift: The Company reported a net income of $1.77 million for the quarter ended March 31, 2007, compared to a net loss of $2.20 million in the same period in 2006. This reversal is primarily driven by a non-cash gain on warrant liabilities of $2.03 million and interest income of $1.15 million, offsetting operating losses.
- Operating Expenses: Total operating expenses decreased to $1.02 million from $2.20 million year-over-year. This reduction is largely due to a decrease in stock-based compensation amortization ($615,051 in 2007 vs. $2.20 million in 2006).
- New Obligations: The Company incurred a "ticking fee" of $162,500 related to the pending InfuSystem acquisition, a cost not present in the prior year.
- Balance Sheet: Cash and cash equivalents decreased by $365,509 from the prior quarter (December 31, 2006) due to the payment of operating expenses and deferred acquisition costs.
Outlook, Risks, and Management Commentary
- Acquisition Status: The Company is actively pursuing the acquisition of InfuSystem. The deal requires stockholder approval and must be consummated by June 29, 2007 (extended from April 30, 2007). If the transaction fails, the Company may be forced to liquidate.
- Financing Structure: The $140 million purchase price will be funded by cash in the trust account and a secured promissory note to I-Flow (initially $55 million, potentially up to $75 million depending on stockholder redemptions).
- Break-Up Fee Risk: If the transaction is terminated under certain conditions, the Company must pay a break-up fee to I-Flow. This fee is guaranteed by the Company's Chairman and another director, backed by a $3 million letter of credit.
- Internal Control Weakness: Management identified a material weakness in financial reporting controls regarding the evaluation of complex transactions and the application of GAAP, specifically concerning the accounting for warrant liabilities. Remedial actions are underway.
- Liquidity Risk: The Company has exhausted cash held outside the trust account. It expects to fund short-term working capital through the sale of warrants. If the acquisition is not completed, the Company may lack sufficient resources to find another target and will likely liquidate.
Key Facts for Investor Verification
- Trust Account Balance: Verify the current balance of the trust account ($99.3 million) and the per-share liquidation value (estimated at $5.88 as of March 31, 2007) in the event of a failed acquisition.
- Stockholder Approval: Confirm the timeline and requirements for the stockholder vote on the InfuSystem acquisition, noting the 20% redemption threshold that could block the deal.
- Warrant Liability Volatility: Understand that the reported net income is heavily influenced by the fair value adjustment of warrant liabilities, which fluctuates with market prices and does not represent cash flow.
- Material Weakness: Review the Company's progress in remedying the identified material weakness in internal controls over financial reporting.
- Break-Up Fee Guaranty: Assess the financial capacity of the individual guarantors (Sean McDevitt and Philip B. Harris) to cover the break-up fee if the Company cannot pay.